Home Biomedical research Global Tissue Banking Market to Surpass US$3.70 Billion by

Global Tissue Banking Market to Surpass US$3.70 Billion by


Seattle, Sept. 05, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the tissue bank market is estimated at US DOLLARS$ 1.63 billion in 2022 and should present a CAGR of 10.8% during the forecast period (2022-2030).

Key trends and analysis of Global tissue banking market:

Companies in the tissue banking market are proactively working in researching and developing new opportunities. For example, in January 2021, biomedical research is supported by the National Investigation Agency (NIA) through several programs that require studying aging in animal models. Non-human primates (NHPs) are important models for studying the biology of aging, including the effects of environmental and social determinants. They also have the potential to provide data more directly transposable to human biology and aging. The National Advisory Council on Aging (NACA) aimed to maximize the use of NHP biological samples already available and to provide a mechanism for multiple researchers to share tissues. The proposed contract will ensure the maintenance and management of a collection of tissues and blood derivatives. In addition, it will expand the scope of non-human primates – NHP-TB, improve coordination with institutions holding NHPs and other tissue banks, increase the number of species and ages, and establish a donor registry for efficient tissue collection.

Additionally, in October 2018, Male to Female (MTF) Biologics announced the formation of a new tissue salvage relationship with Regenerative Biologics, Inc., Biotechnology Research Center. Organizations will seek to provide expanded opportunities for genital tissue donation to pregnant women and their families and to improve patient access to high-quality placental tissue for wound care applications.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/2600

Main market takeaways:

The global tissue bank market is expected to grow at a CAGR of 10.8% during the forecast period owing to the increasing funding from the capital market company. For example, in September 2021, OrbiMed Advisors LLC, Capital Market Company, is funding LifeCell International, Stem Cell Bank with US$255 billion to meet growth capital needs and foray into adjacent stem cell units. The funds will help develop plans for growth in stem cell storage divisions. LifeCell seeks to further leverage its technology expertise, strong brand position and extensive network to enter new adjacent categories such as fertility health and cell therapies. Funds raised by OrbiMed will help accelerate this program and further strengthen LifeCell’s market position.

On the basis of product, the media and consumables segment is expected to lead the growth of the segment over the forecast period, owing to the launch of new products in the market. For example, in May 2022, the largest US report on elective fertility preservation outcomes to date found that 70% of women who froze eggs when they were under 38 – and thawed at least 20 eggs at a later date – had a baby. Led by experts from NYU Grossman School of Medicine and NYU Langone Fertility Center, the new discovery was based on 15 years of actual results from thawing frozen eggs for women who had delayed childbearing and were facing declining natural age-related fertility.

Competitive Landscape:

Key players operating in the global tissue banking market include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation and Teva Pharmaceutical Industries Ltd.

Buy now this research report @ https://www.coherentmarketinsights.com/insight/buy-now/2600

Market segmentation :

  • Global tissue banking market, by product:
    • Media and Consumables
    • Equipment
      • Cryopreservation equipment
      • Quality control equipment
      • Thawing equipment
      • Others
  • Global tissue banking market, by tissue type:
    • Bone
    • Brain and spinal cord
    • Cornea
    • Heart valves
    • Skin
    • Others
  • Global tissue banking market, by region:
    • North America
    • Latin America
      • By country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By country
        • Germany
        • UK
        • France
        • Italy
        • Spain
        • Russia
        • The rest of Europe
    • Asia Pacific
      • By country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia-Pacific
    • Middle East
      • By country
        • GCC
        • Israel
        • Rest of the Middle East
    • Africa
      • By region/country
        • South Africa
        • central Africa
        • North Africa

Related Market Information Reports:

Cellular Cryopreservation Marketby Product Type (Cryoprotective Agents (Glycerol, Dimethyl Sulfoxide (DMSO), Others) and Equipment), by Application (Stem Cells, Oocytes and Embryos, Sperm, Sperm and Testicular Tissue, Hepatocytes and Others), by End User (Pharmaceutical Companies and biotechnology, academic and research institutes, biobank and others), and by region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) – Analysis of the size, share, prospects and opportunities, 2022 – 2030

tissue engineering marketby material type (synthetic, biologic and others), by application (dermal, orthopedic, dental, neurological and others) and by region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) – Analysis in size, share, prospects and opportunities, 2022 – 2030

About Us:

Consistent market information is a global market intelligence and advisory organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. Our head office is in India, with a sales office in the world’s financial capital in the USA and sales advisors in the UK and Japan. Our customer base includes players from various industries in more than 57 countries around the world. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leading role in providing insight in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Follow us: LinkedIn | Twitter